4/27/2012

Patients with atrial fibrillation who discontinued anticoagulant treatment were at greater risk for strokes and blood clots, according to a study from researchers at Duke University and UCLA. The risk of excessive bleeding was similar for those taking warfarin and rivaroxaban.

Full Story:
HealthDay News

Related Summaries